Jolley Asset Management buys $396,187 stake in Monsanto Company (MON)

Monsanto Company (MON) : Jolley Asset Management scooped up 3,000 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 17, 2016. The investment management firm now holds a total of 3,880 shares of Monsanto Company which is valued at $396,187.Monsanto Company makes up approximately 0.33% of Jolley Asset Management’s portfolio.

Other Hedge Funds, Including , Sonora Investment Management boosted its stake in MON in the latest quarter, The investment management firm added 400 additional shares and now holds a total of 1,287 shares of Monsanto Company which is valued at $131,416. Monsanto Company makes up approx 0.07% of Sonora Investment Management’s portfolio.Carroll Financial Associates boosted its stake in MON in the latest quarter, The investment management firm added 278 additional shares and now holds a total of 4,336 shares of Monsanto Company which is valued at $446,478. Monsanto Company makes up approx 0.07% of Carroll Financial Associates’s portfolio.Exxonmobil Investment Management Inc Tx reduced its stake in MON by selling 1,348 shares or 1.19% in the most recent quarter. The Hedge Fund company now holds 111,729 shares of MON which is valued at $11,548,309. Monsanto Company makes up approx 0.24% of Exxonmobil Investment Management Inc Tx’s portfolio.Washington Trust Bank boosted its stake in MON in the latest quarter, The investment management firm added 33 additional shares and now holds a total of 560 shares of Monsanto Company which is valued at $57,781. Monsanto Company makes up approx 0.01% of Washington Trust Bank’s portfolio.

Monsanto Company closed down -0.43 points or -0.42% at $102.11 with 32,17,128 shares getting traded on Friday. Post opening the session at $102.68, the shares hit an intraday low of $101.64 and an intraday high of $102.8 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Monsanto Company reported $0.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Oct 5, 2016. Analyst had a consensus of $-0.03. The company had revenue of $2562.00 million for the quarter, compared to analysts expectations of $2379.03 million. The company’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.19 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Shares were Reiterated by Monness Crespi & Hardt on Oct 3, 2016 to “Buy” and Lowered the Price Target to $ 128 from a previous price target of $130 .Monsanto Company was Upgraded by Goldman to ” Neutral” on Sep 27, 2016. Monsanto Company was Upgraded by Bernstein to ” Mkt Perform” on Sep 26, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.